NKF-INS Glargine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NKF-INS Glargine, covering 2025-07-16 to 2025-07-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS Glargine (G), United States (US)-Lantus®, and European Union (EU)-Lantus® [Phase 1]